Robbins; Joan M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Robbins; Joan M..The latest application filed is for "car t cell methods and constructs".

Company Profile

0.5.13

Robbins; Joan M. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Car T Cell Methods And Constructs App 20220090132 - Jolly; Douglas J. ; et al.	2022-03-24
Retroviral vector having immune-stimulating activity Grant 11,230,719 - Gruber , et al. January 25, 2	2022-01-25
Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors App 20210361691 - Gruber; Harry E. ; et al.	2021-11-25
Armed Replication-competent Oncolytic Adenoviruses App 20180169271 - Cantwell; Mark J. ; et al.	2018-06-21
Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors App 20180021365 - Gruber; Harry E. ; et al.	2018-01-25
Retroviral Vector Having Immune-stimulating Activity App 20170175137 - Gruber; Harry E. ; et al.	2017-06-22
Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders Grant 9,669,049 - Gruber , et al. June 6, 2	2017-06-06
Cancer combination therapy and recombinant vectors Grant 9,642,921 - Robbins , et al. May 9, 2	2017-05-09
Cancer Combination Therapy And Recombinant Vectors App 20140178340 - Robbins; Joan M. ; et al.	2014-06-26
Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors App 20130323301 - Gruber; Harry E. ; et al.	2013-12-05
Cancer Treatment With Recombinant Vector App 20130130986 - Gruber; Harry E. ; et al.	2013-05-23
Stable Pharmaceutical Compositions Of 5, 10 Methylenetrahydrofolate App 20090221594 - Chen; Andrew X. ; et al.	2009-09-03
Use of 5,10-Methylene Tetrahydrofolate for the Treatment of Cancer App 20070280944 - Robbins; Joan M. ; et al.	2007-12-06
Ribozyme therapy for the treatment of proliferative skin and eye diseases App 20060178326 - Robbins; Joan M. ; et al.	2006-08-10
Ribozyme therapy for the treatment of proliferative skin and eye diseases Grant 6,770,633 - Robbins , et al. August 3, 2	2004-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.